Welcome to our dedicated page for Novanta news (Ticker: NOVT), a resource for investors and traders seeking the latest updates and insights on Novanta stock.
Novanta Inc. reports developments as a Nasdaq-listed supplier of core technology solutions for medical, life science and advanced industrial original equipment manufacturers. Its updates center on precision medicine, precision manufacturing, robotics and automation, and advanced surgery, including laser beam steering and scanning, laser sources, robotic and precision motion technologies, medical insufflators, endoscopic pumps and integrated operating room technologies.
Company news commonly covers quarterly earnings releases, conference calls, investor presentations, OEM design wins, product and technology collaborations, and capital actions tied to balance-sheet and securities structure. Recent themes include motion control and sensing technologies for robotics certification environments and tangible equity unit financing.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Novanta Inc. (NASDAQ: NOVT) will release its Q1 2023 results on May 9, 2023. A conference call is scheduled for 10:00 a.m. ET on the same day to discuss the financial performance. Investors can participate by dialing (888) 346-3959 or through a live webcast available on the company’s website. A replay of the call will be accessible approximately three hours after its conclusion and will remain available until July 3, 2023. Novanta is recognized as a leading global supplier of technology solutions for healthcare and industrial OEMs, providing advanced components and systems designed for precision and superior performance.
Novanta reported a strong financial performance for the full year 2022, with GAAP revenue increasing by 22% to $861 million and net income rising to $74 million. The company achieved a 46% increase in diluted EPS, reaching $2.06. Adjusted EPS also grew by 17% to $3.07, while adjusted EBITDA was reported at $184 million. For Q4 2022, revenue rose 9.8% to $218.4 million. Looking ahead, Novanta projects 2023 GAAP revenue between $890 million and $915 million with adjusted diluted EPS expected between $3.00 and $3.20.
Novanta Inc. (NASDAQ: NOVT) will announce its fourth quarter and full year 2022 results on March 1, 2023. The company is a trusted partner for medical and advanced technology equipment manufacturers, offering core technology solutions to enhance performance. A conference call is scheduled for 10:00 a.m. ET on the same day to discuss results, accessible via phone or a live webcast through its website. A replay of the call will be available for three hours after the event until April 3, 2023. For more information, visit Novanta's website.
Novanta Inc. (NASDAQ: NOVT), a leader in technology solutions for medical and advanced technology equipment manufacturers, announced that Robert Buckley, CFO, and Chuck Ravetto, Group President, will present at the CJS Securities 23rd Annual New Ideas for the New Year Investor Conference on Wednesday, January 11, 2023. The conference will be held virtually, highlighting Novanta's commitment to innovation and customer success as they deliver precise technology solutions to OEMs.